Back to Search
MOHAMAD ATASSI, MD
MD
Cardiovascular Disease Physician
NPI: 1073508172IndividualAccepts Medicare
Specialties, Licenses & Credentials
Cardiovascular Disease PhysicianPrimary
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
036062020(IL)
Education
OTHER
Class of 1977
Research & Publications (20)
Immune recognition of BoNTs A and B: how anti-toxin antibodies that bind to the heavy chain obstruct toxin action.
PMID 19285100·Toxicon·2009
4-observational
[Contribution of NMR to the assessment of dyslipidemia-related cardiovascular risk].
PMID 18706340·Ann Pharm Fr·2008
6-review
Molecular recognition of botulinum neurotoxin B heavy chain by human antibodies from cervical dystonia patients that develop immunoresistance to toxin treatment.
PMID 18676021·Mol Immunol·2008
7-preclinical
Neutralizing antibodies in dystonic patients who still respond well to botulinum toxin type A.
PMID 18809844·Neurology·2008
8-other
Immune recognition of botulinum neurotoxin B: antibody-binding regions on the heavy chain of the toxin.
PMID 17897717·Mol Immunol·2008
7-preclinical
The binding sites on botulinum neurotoxin B for synaptotagmin and for blocking antibodies.
PMID 18796292·Biochem Biophys Res Commun·2008
8-other
Preface: Immunology of protein and peptide therapies.
PMID 18197817·Crit Rev Immunol·2007
7-preclinical
Dedication: John Jacob "Jack" Marchalonis, PhD, 1940-2007.
PMID 18197816·Crit Rev Immunol·2007
8-other
Molecular bases of protective immune responses against botulinum neurotoxin A--how antitoxin antibodies block its action.
PMID 18197812·Crit Rev Immunol·2007
6-review
The lateral pterygoid muscle, a heterogeneous unit implicated in temporomandibular disorder: a literature review.
PMID 17983128·Cranio·2007
6-review
Mapping of the regions on the heavy chain of botulinum neurotoxin A (BoNT/A) recognized by antibodies of cervical dystonia patients with immunoresistance to BoNT/A.
PMID 16647121·Mol Immunol·2007
7-preclinical
Targeting the antigen-binding site of HLA-restricting alleles in treatment of autoimmune disease.
PMID 18197821·Crit Rev Immunol·2007
6-review
Marked efficacy of a therapeutic strategy associating prednisone and plasma exchange followed by rituximab in two patients with refractory myopathy associated with antibodies to the signal recognition particle (SRP).
PMID 16616848·Neuromuscul Disord·2006
5-case
Clinico-immunologic aspects of botulinum toxin type B treatment of cervical dystonia.
PMID 17190952·Neurology·2006
3-trial
Subtle differences in HLA DQ haplotype-associated presentation of AChR alpha-chain peptides may suffice to mediate myasthenia gravis.
PMID 16891216·Autoimmunity·2006
8-other
On the enhancement of anti-neurotoxin antibody production by subcomponents HA1 and HA3b of Clostridium botulinum type B 16S toxin-haemagglutinin.
PMID 16804163·Microbiology (Reading)·2006
7-preclinical
Use of alum and inactive Bordetella pertussis for generation of antibodies against synthetic peptides in mice.
PMID 16698673·Immunol Invest·2006
7-preclinical
Myasthenia gravis induced in mice by immunization with the recombinant extracellular domain of rat muscle-specific kinase (MuSK).
PMID 16697051·J Neuroimmunol·2006
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6625 S PULASKI RD
CHICAGO, IL 60629 - Phone
- (773) 585-1555
Quick Facts
- NPI
- 1073508172
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 49
- Publications
- 20
Are you this provider?
Claim Your Profile